FY2025 EPS Estimates for Omeros Cut by Cantor Fitzgerald
Omeros Co. (NASDAQ:OMER – Free Report) – Analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for shares of Omeros in a research report issued to clients and investors on Wednesday, April 2nd. Cantor Fitzgerald analyst O. Brayer now forecasts that the biopharmaceutical company will post earnings of ($2.19) per share for the year, down […]
Omeros Co. (NASDAQ:OMER – Free Report) – Analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for shares of Omeros in a research report issued to clients and investors on Wednesday, April 2nd. Cantor Fitzgerald analyst O. Brayer now forecasts that the biopharmaceutical company will post earnings of ($2.19) per share for the year, down […]